World Cardiology 2020 is immensely pleased to invite all the researchers for our upcoming “2nd World Cardiology and Cardiac Rehabilitation Meeting” at Athens, Greece during July 01-02, 2020 with a theme “Promoting Excellence in Cardiology and Healthcare”

World Cardiology 2020  will join world-class professors, scientists, researchers, students, Young Researchers, Perfusionists, cardiologists to discuss methodology for ailment remediation for heart diseases, Electrocardiography, Heart Failure, Pediatric Cardiology and health disorders.

Cardiology Conferences is s designed to provide varying and flow planning to hold helpful specialists next to each other about the issues affecting cardiac pollution anticipation, finding and care.

Cardiology Conferences gives a complete overview on Current Research on Cardiology - Future Medicine, Cardio-Oncology and Nuclear Cardiology, Pediatric Cardiac Nanomedicine, Congenital Heart Disease and Pediatrics, Molecular Cardiology, Myocarditis and Cardiomyopathies, Cardiothoracic Surgery and  many more.

CONFERENCE OPPORTUNITIES:

• Keynote Presentations
• Speaker Presentations
• Yong Researcher Forum (YRF)
• Poster Presentation
• Video Presentation
• E-Poster
• Work Shop
• Exhibition
• Symposium
• Collaboration
• Sponsorship

Market Analysis: The global cardiovascular drugs market is predictable to reach the value of approximately US$ 91.0 Bn by 2025. Cardiovascular diseases are one of the important causes of death worldwide. According to American Heart Association, it is valued that cardiovascular disease is likely to increase to 45% by 2035. Sedentary lifestyle, changing dietary habits and surge in supplementary risk factors are likely to increase the number of patients with cardiovascular diseases. Drug classes used to treat cardiovascular indications such as hyperlipidemia, hypertension are likely to fuel expansion of the global cardiovascular drugs market from 2017 to 2025. According to the Centers for Disease Control and Prevention (CDC) of the U.S., high blood pressure, high cholesterol, and smoking are key risk factors for heart disease. About half of the populations of the U.S. (47%) have at least one of these three risk factors. To treat the diseases, key players are investing in to develop new drugs with better efficacy and fewer side effects.

For any further details, benefits, submission of research papers, participation, please contact:

Ashley Osteen
Program Director | World Cardiology 2020
Whatsapp: 44-202-108-0002
Email: cardiology@europemeet.com | enquiry@europeconferences.com
Web: https://worldcardiology.cardiologymeeting.com/